Zydus Therapeutics Inc.

Works in GI & liver · Metabolic & endocrine · Neurology · Renal & urogenital · Women's health

Zydus Therapeutics Inc. is a clinical trial sponsor. It has 6 active clinical trials with 854 planned participants, across 5 therapeutic areas. Since 2021 it has completed 8 trials and stopped 3 early.

Trial track record · since 2021

6Active trials854 planned participants
8Completed6 with results posted
3Stopped early27% of finished trials

Pipeline · 6 active trials

StageTrialStatus

Questions about Zydus Therapeutics Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-21.

Approve Suite is not affiliated with Zydus Therapeutics Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.